Rho GTPases as therapeutic targets in Alzheimer's disease

BJ Aguilar, Y Zhu, Q Lu - Alzheimer's research & therapy, 2017 - Springer
The progress we have made in understanding Alzheimer's disease (AD) pathogenesis has
led to the identification of several novel pathways and potential therapeutic targets. Rho …

[HTML][HTML] From microcirculation to aging-related diseases: a focus on endothelial SIRT1

M Law, PC Wang, ZY Zhou, Y Wang - Pharmaceuticals, 2024 - mdpi.com
Silent information regulator sirtuin 1 (SIRT1) is an NAD+-dependent deacetylase with potent
anti-arterial aging activities. Its protective function in aging-related diseases has been …

Remodeling of the postsynaptic proteome in male mice and marmosets during synapse development

T Kaizuka, T Suzuki, N Kishi, K Tamada… - Nature …, 2024 - nature.com
Postsynaptic proteins play crucial roles in synaptic function and plasticity. During brain
development, alterations in synaptic number, shape, and stability occur, known as synapse …

Pharmacological modulators of small GTPases of rho family in neurodegenerative diseases

W Guiler, A Koehler, C Boykin, Q Lu - Frontiers in Cellular …, 2021 - frontiersin.org
Classical Rho GTPases, including RhoA, Rac1, and Cdc42, are members of the Ras small
GTPase superfamily and play essential roles in a variety of cellular functions. Rho GTPase …

Proteomics analysis of prefrontal cortex of Alzheimer's disease patients revealed dysregulated proteins in the disease and novel proteins associated with amyloid-β …

A Montero-Calle, R Coronel… - Cellular and Molecular …, 2023 - Springer
Background Alzheimer's disease (AD) is a progressive, chronic, and neurodegenerative
disease, and the most common cause of dementia worldwide. Currently, the mechanisms …

Rac1 activation links tau hyperphosphorylation and Aβ dysmetabolism in Alzheimer's disease

M Borin, C Saraceno, M Catania, E Lorenzetto… - Acta Neuropathologica …, 2018 - Springer
One of the earliest pathological features characterizing Alzheimer's disease (AD) is the loss
of dendritic spines. Among the many factors potentially mediating this loss of neuronal …

[HTML][HTML] Glucocorticoid receptors modulate dendritic spine plasticity and microglia activity in an animal model of Alzheimer's disease

M Pedrazzoli, M Losurdo, G Paolone, M Medelin… - Neurobiology of …, 2019 - Elsevier
Chronic exposure to high circulating levels of glucocorticoids (GCs) may be a key risk factor
for Alzheimer's Disease (AD) development and progression. In addition, hyper-activation of …

A nexus of miR-1271, PAX4 and ALK/RYK influences the cytoskeletal architectures in Alzheimer's Disease and Type 2 Diabetes

P Majumder, K Chanda, D Das, BK Singh… - Biochemical …, 2021 - portlandpress.com
Alzheimer's Disease (AD) and Type 2 Diabetes (T2D) share a common hallmark of insulin
resistance. Reportedly, two non-canonical Receptor Tyrosine Kinases (RTKs), ALK and …

Pyk2 signaling through Graf1 and RhoA GTPase is required for amyloid-β oligomer-triggered synapse loss

S Lee, SV Salazar, TO Cox… - Journal of …, 2019 - Soc Neuroscience
The intracellular tyrosine kinase Pyk2 (PTK2B) is related to focal adhesion kinase and
localizes to postsynaptic sites in brain. Pyk2 genetic variation contributes to late onset …

The evaluation of Rac1 signaling as a potential therapeutic target of Alzheimer's disease

H Wang, Y Yamahashi, M Riedl, M Amano… - International journal of …, 2023 - mdpi.com
The Small GTPase Rac1 is critical for various fundamental cellular processes, including
cognitive functions. The cyclical activation and inactivation of Rac1, mediated by Rac …